Brean Capital Upgrades Xylem (XYL) to Buy
Brean Capital upgraded Xylem (NYSE: XYL) from Hold to Buy with a price target of $44.00. Analyst Michael Gaugler believes ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
